PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 12005553

Rapid fluorescence ratio assay for detecting changes in radiosensitivity.

I Hofland·B Ramakers·A C Begg·C Vens
View original source ↗Export metadata ↓

Abstract

To test modifications in sensitization to radiation or drugs in preclinical studies of cancer therapy, the colony-forming assay is regarded as the gold standard. Because this assay is time consuming, somewhat laborious, and unsuitable for rapid screening, development of other assays is desirable. We describe here an assay based on the detection of enhanced green fluorescence protein (EGFP) with flow cytometry that is particularly suitable for genetic manipulation studies in which the gene of interest is introduced together with EGFP as reporter. It is easily adaptable to other reporters, however, whether naturally fluorescent or requiring immunochemical staining. Cells are irradiated as mixed populations of a known standard cell line (nonfluorescent) together with the genetically manipulated cell line expressing EGFP. Ratios of fluorescent and nonfluorescent cells are measured before treatment and several days after treatment. If the cell populations have equal radiosensitivities, the ratio remains unchanged. Changes in the ratio indicate changes in radiosensitivity. The assay was validated for two situations in which dominant negative peptides inhibiting DNA repair were expressed in A549 human lung cells and affected radiosensitivity.

Explore related subjects

Cell DeathCell SurvivalDNA Polymerase betaDNA RepairDose-Response Relationship, RadiationFlow CytometryFluorescenceGreen Fluorescent ProteinsHumansLuminescent ProteinsRadiation ToleranceTumor Cells, CulturedJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

I Hofland, B Ramakers, A C Begg, C Vens. 2002. Rapid fluorescence ratio assay for detecting changes in radiosensitivity.. https://doi.org/10.1667/0033-7587(2002)157%5B0734%3Arfrafd%5D2.0.co%3B2

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2024

Designer TALEs enable discovery of cell death-inducer genes.

Transcription activator-like effectors (TALEs) in plant-pathogenic Xanthomonas bacteria activate expression of plant genes and support infection or cause a resistance response. PthA4AT is a TALE with a particularly short DNA-binding domain harboring only 7.5 repeats which triggers cell death in Nicotiana benthamiana; however, the genetic basis for this remains unknown. To identify possible target genes of PthA4AT that mediate cell death in N. benthamiana, we exploited the modularity of TALEs to stepwise enhance their specificity and reduce potential target sites. Substitutions of individual repeats suggested that PthA4AT-dependent cell death is sequence specific. Stepwise addition of repeats to the C-terminal or N-terminal end of the repeat region narrowed the sequence requirements in promoters of target genes. Transcriptome profiling and in silico target prediction allowed the isolation of two cell death inducer genes, which encode a patatin-like protein and a bifunctional monodehydroascorbate reductase/carbonic anhydrase protein. These two proteins are not linked to known TALE-dependent resistance genes. Our results show that the aberrant expression of different endogenous plant genes can cause a cell death reaction, which supports the hypothesis that TALE-dependent executor resistance genes can originate from various plant processes. Our strategy further demonstrates the use of TALEs to scan genomes for genes triggering cell death and other relevant phenotypes.

Cell Death↗
PubMed2007

The dopaminergic nigrostriatal system and Parkinson's disease: molecular events in development, disease, and cell death, and new therapeutic strategies.

For several decades, the clinical study of Parkinson's disease has driven an increasingly sophisticated understanding of the dopaminergic system and its complex role in modulating motor behavior. This article reviews salient areas of research in this field, commencing with the molecular biology of the development of the mesencephalic dopaminergic system. We then discuss events thought to be crucial in the cellular and molecular pathology of Parkinson's disease, proposed mechanisms of cell death, and relevant toxin models. These advancements are used as a template to review emerging therapeutic techniques, including neuroprotection strategies, surgical treatment of trophic factors, gene therapy, and neural transplantation.

Cell Death↗
PubMed2007

In vitro cytotoxicity assessment.

The most frequent reason cited for withdrawal of an approved drug is toxicity, yet no simple solution exists to adequately predict such adverse effects. Compound prioritization and optimization during in vitro screening cascades need to be based on confidence, not only in efficacy and bioavailability, but also in safety. A wider number and diversity of potential molecular and cellular effects of compound interactions might affect safety than might affect efficacy or bioavailability. Accordingly, cytotoxicity assessment is less specific, more multiparametric, and extrapolatable with less certainty, unless there are specific safety signals indicated by the chemical structure or by precedents. Cytotoxicity assessments have been limited by their inability to measure multiple, mechanistic parameters that capture a wide spectrum of potential cytopathological changes. Assays with multiple parameters for key, multiple, and different features, such as in high content screening (HCS), are more predictive because they cover a wider spectrum of effects. Assays need to be applied to a large set of marketed drugs that produce toxicity by numerous and different mechanisms for assessment of correlation with human toxicity. This will enable determination of the concordance between in vitro and in vivo results. Multiparametric, live cell, prelethal cytotoxic HCS assays for assessing the potential of compounds for causing human toxicity address some of the limitations of traditional in vitro methods. Assays of this class were used to screen a library of drugs with varying degrees of toxicity and it was found that the sensitivity of the assays was 87%, whereas assay specificity was more than 90%, thereby minimizing false positives.

Cell Death↗